Alcohol

Alcohol

SCHEMBL8992083

CCO.CO[C@H]1O[C@H](COCc2ccccc2)[C@@H](CO)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SSTR1 P30872 1/20 0.54
SSTR2 P30874 1/20 0.54
SSTR4 P31391 1/20 0.54
SSTR3 P32745 1/20 0.54
SSTR5 P35346 1/20 0.54
PTPN1 P18031 9/20 0.48
PTPN2 P17706 4/20 0.48
CDC25B P30305 6/20 0.46
GJB2 P29033 1/20 0.46
NT5E P21589 1/20 0.45
BCHE P06276 1/20 0.44
PTPN6 P29350 2/20 0.43
PTPN11 Q06124 2/20 0.43
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8992112 0.98 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992144 0.92 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992149 0.92 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992062 0.91 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992067 0.91 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL6667240 0.88 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL18671706 0.88 SSTR1 (0.56) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL16560345 0.86 SSTR1 (0.52) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL3752664 0.85 SSTR1 (0.70) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL6872203 0.85 SSTR1 (0.70) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5504078-A α-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1996-04-02 US disclosed
EP-0532668-B1 NOVEL ALPHA-GLUCOSIDASE INHIBITORS MERRELL DOW PHARMA (US) 1995-11-15 EP disclosed
EP-0345104-B1 Novel Alpha-glucosidase inhibitors MERRELL DOW PHARMA (US) 1995-11-02 EP disclosed
EP-0422975-B1 Alpha-glucosidase inhibitors MERRELL DOW PHARMA (US) 1994-07-27 EP disclosed
US-5157116-A Antidiabetic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-20 US disclosed
US-5097023-A α-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-17 US disclosed
EP-0422975-A1 Alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 EP disclosed
EP-0422307-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 EP disclosed
EP-0389723-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-10-03 EP disclosed
EP-0390674-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-10-03 EP disclosed
EP-0344383-A1 Novel alpha-Glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-06 EP disclosed
EP-0345104-A2 Novel Alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-06 EP disclosed